form424b3.htm
Filed Pursuant to Rule
424(b)(3)
Registration No.
333-132577
PROSPECTUS
11,512,137
Shares
Common
Stock
This
prospectus relates to the offer and sale from time to time of up to an aggregate
of 11,512,137 shares of common stock for the account of the selling stockholder
named in this prospectus. The selling stockholder may sell none, some
or all of the shares offered by this prospectus. We cannot predict when or in
what amounts the selling stockholder may sell any of the shares offered by this
prospectus. The price or prices at which the selling stockholder may
sell shares of common stock will be determined by prevailing market prices for
the shares or in negotiated transactions. We will not receive any
proceeds from sales by the selling stockholder.
On March
3, 2006, we acquired the hydraulic workover business of Oil States
International, Inc., a Delaware corporation, from its wholly owned subsidiary,
Oil States Energy Services, Inc. (formerly known as HWC Energy Services, Inc.).
In connection with the acquisition, we issued shares of our common stock to Oil
States Energy Services, Inc. We also entered into a registration
rights agreement with Oil States Energy Services pursuant to which we agreed to
file with the U.S. Securities and Exchange Commission a registration statement
covering resales of the shares of common stock we issued to Oil States Energy
Services. This prospectus forms a part of the registration statement
filed by us as required by the registration rights agreement. We will
pay all of the expenses incurred in registering the shares.
Investing
in our common stock involves significant risks. See "Risk Factors"
beginning on page 2 of this prospectus.
Our
common stock is quoted on the American Stock Exchange under the symbol “WEL.” On
May 7, 2008, the last reported sales price for our common stock was $2.16 per
share.
Neither
the Securities and Exchange Commission nor any state securities commission has
approved or disapproved of these securities or determined if this prospectus is
truthful or complete. Any representation to the contrary is a criminal
offense.
The date
of this Prospectus is May 8, 2008.
TABLE
OF CONTENTS
ABOUT
THIS PROSPECTUS
|
i
|
PROSPECTUS
SUMMARY
|
1
|
RISK
FACTORS
|
2
|
INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE
|
2
|
USE
OF PROCEEDS
|
2
|
DESCRIPTION
OF OUR CAPITAL STOCK
|
3
|
SELLING
STOCKHOLDERS
|
8
|
PLAN
OF DISTRIBUTION
|
8
|
LEGAL
MATTERS
|
11
|
EXPERTS
|
11
|
WHERE
YOU CAN FIND MORE INFORMATION
|
11
|
FORWARD−LOOKING
STATEMENTS
|
11
|
ABOUT
THIS PROSPECTUS
You
should rely only on the information contained or incorporated by reference in
this prospectus. We have not authorized anyone to provide you with
different information. You should not assume that the information in
this registration statement or any related prospectus or prospectus supplement,
including any information incorporated herein by reference, is accurate as of
any date other than the date on the front of the applicable document, or such
earlier date as is expressly stated or otherwise apparent with respect to such
incorporated information in the applicable document, regardless of the time of
delivery of this prospectus, any prospectus supplement or any sale of our common
stock. Our business, financial condition, results of operations and
prospects may have changed since any such date. The selling
stockholder is not making an offer to sell these securities in any jurisdiction
where the offer or sale is not permitted.
PROSPECTUS
SUMMARY
The
following summary should be read together with the information contained in
other parts of this prospectus and the documents we incorporate by reference. It
likely does not contain all of the information that is important to you or that
you should consider when making an investment decision. You should
read this entire prospectus, including all documents incorporated by reference,
carefully, especially “Risk Factors” and our consolidated financial statements
and related notes incorporated by reference herein. Please see the
section entitled “Where You Can Find More Information.” In this
prospectus, we refer to Boots & Coots International Well Control, Inc., and
its subsidiaries as “we,” “us,” “our” or “Boots & Coots,” unless we
specifically indicate otherwise or the context clearly indicates
otherwise.
Our
Company
We
provide a suite of integrated pressure control and related services to onshore
and offshore oil and gas exploration and development companies; principally in
North America, South America, North Africa, West Africa and the Middle
East. Our customers include major and independent oil and gas
companies in the U.S. market and major international and foreign national oil
and gas producers as well as other oilfield service companies. Our
service lines are organized into two business segments; well intervention and
response. Our well intervention segment consists of services that are
designed to enhance production for oil and gas operators and to reduce the
number and severity of critical events such as oil and gas well fires, blowouts
or other incidences due to loss of control at the well. This business segment
consists primarily of hydraulic workover and snubbing services, prevention and
risk management services and pressure control equipment rental and
services. Our response segment consists of personnel, equipment and
emergency services utilized during a critical well event. We have a
long history in the oil and gas industry and are widely recognized for our
emergency response services.
Our
principal offices are located at 7908 N. Sam Houston Parkway W., 5th Floor,
Houston, Texas 77064, and our telephone number is (281) 931-8884. Our website is
located at www.bootsandcoots.com.
The
Offering
This
prospectus relates to the offer and sale from time to time of up to an aggregate
of 11,512,137 shares of common stock for the account of the selling stockholder
named in this prospectus. The selling stockholder may sell none, some
or all of the shares offered by this prospectus. We cannot predict when or in
what amounts the selling stockholder may sell any of the shares offered by this
prospectus. The price or prices at which the selling stockholder may
sell shares of common stock will be determined by prevailing market prices for
the shares or in negotiated transactions.
We will
not receive any proceeds from the sale of securities by the selling
stockholders. See “ Use of Proceeds”
on page 2 of this
prospectus.
RISK
FACTORS
Before
deciding to purchase, hold or sell our common stock, you should carefully
consider the risks, cautionary statements and other information contained in
this prospectus and in our other filings with the SEC that we incorporate by
reference, including our Annual Report on Form 10−K for the fiscal year ended
December 31, 2007. The risks and uncertainties described in these documents are
not the only ones we face. Additional risks and uncertainties not presently
known to us or that we currently deem immaterial may also affect our business.
If any of these known or unknown risks or uncertainties actually occurs with
material adverse effects on our company, our business, financial condition,
results of operation and/or liquidity could be seriously harmed. In that event,
the market price for our common stock will likely decline, and you may lose all
or part of your investment.
INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE
We have
elected to “incorporate by reference” certain information into this prospectus.
By incorporating by reference, we can disclose important information to you by
referring you to another document we have filed with the SEC. The information
incorporated by reference is deemed to be part of this prospectus, except for
information incorporated by reference that is superseded by information
contained in this prospectus. This prospectus incorporates by reference the
documents set forth below that we have previously filed with the
SEC:
· Our
Annual Report on Form 10−K for the fiscal year ended December 31, 2007 filed
with the SEC on March 13, 2008;
You
should read the information relating to us in this prospectus together with the
information in the documents incorporated by reference.
You may
obtain a copy of any of the above−referenced documents, at no cost, from our
website at www.bootsandcoots.com. The
information contained in, or that can be accessed through, our website is not
part of this prospectus. We will also furnish without charge to you, on written
or oral request, a copy of any or all of the documents incorporated by
reference, including exhibits to these documents. You should direct your
requests for documents to:
Director,
Investor Relations
Boots
& Coots International Well Control, Inc.
7908 N.
Sam Houston Parkway W., 5th
Floor
Houston,
Texas 77064
(281)
931−8111
USE
OF PROCEEDS
This
prospectus relates to the offer and sale from time to time of up to an aggregate
of 11,512,137 shares of common stock for the account of the selling stockholder
referred to in this prospectus. We will not receive any of the proceeds from the
sale of any shares of common stock by the selling stockholder. Please read
“Selling Stockholder” for the name of the
selling stockholder receiving proceeds from the sale of the common stock
covered by this prospectus.
DESCRIPTION
OF OUR CAPITAL STOCK
The
following description of our common stock, preferred stock, certificate of
incorporation, by-laws and rights agreement is a summary only and is subject to
the complete text of our certificate of incorporation and by-laws and the rights
agreement we have entered into with American Stock Transfer & Trust Company,
as Rights Agent, which we have previously filed with the SEC. You should read
our certificate of incorporation, by-laws and rights agreement as currently in
effect for more details regarding the provisions we describe below and for other
provisions that may be important to you. You may request copies of these
documents by writing or telephoning us at our address and telephone number shown
under the caption "Where You Can Find More Information." This section also
summarizes relevant provisions of the Delaware General Corporation Law. The
terms of the Delaware General Corporation Law are more detailed than the general
information provided below. Therefore, you should carefully consider the actual
provisions of these laws.
Our
authorized capital stock currently consists of 125,000,000 shares of common
stock, par value $0.00001 per share, and 5,000,000 shares of preferred stock,
par value $0.00001 per share. As of the date of this prospectus, there are
approximately 75,776,581 million shares of common stock issued and outstanding
and approximately 200 stockholders of record of our common stock. No shares of
preferred stock are currently outstanding.
Common
Stock
The
holders of our common stock are entitled to one vote per share on all matters to
be voted on by stockholders generally, including the election of directors.
There are no cumulative voting rights, meaning that the holders of a majority of
the shares voting for the election of directors can elect all of the candidates
standing for election.
Our
common stock carries no preemptive or other subscription rights to purchase
shares of our stock and is not convertible, redeemable or assessable or entitled
to the benefits of any sinking fund. Holders of our common stock will be
entitled to receive such dividends as may from time to time be declared by our
board of directors out of funds legally available for the payment of dividends.
If we issue preferred stock in the future, payment of dividends to holders of
our common stock may be subject to the rights of holders of our preferred stock
with respect to payment of preferential dividends, if any.
If we are
liquidated, dissolved or wound up, the holders of our common stock will share
pro rata in our assets after satisfaction of all of our liabilities and the
prior rights of any outstanding class of our preferred stock.
Our
common stock is listed on the American Stock Exchange under the symbol
“WEL.”
Preferred
Stock
Our board
of directors has the authority, without stockholder approval, to issue up to
five million shares of preferred stock in one or more series and to fix the
rights, preferences, privileges and restrictions thereof, including dividend
rights, dividend rates, conversion rates, voting rights, terms of redemption,
redemption prices, liquidation preferences and the number of shares constituting
any series or the designation of that series, which may be superior to those of
the common stock, without further vote or action by the stockholders. One of the
effects of undesignated preferred stock may be to enable our board of directors
to render more difficult or to discourage an attempt to obtain control of us by
means of a tender offer, proxy contest, merger or otherwise, and as a result to
protect the continuity of our management. The issuance of shares of the
preferred stock by the board of directors as described above may adversely
affect the rights of the holders of common stock. For example, preferred stock
issued by us may rank superior to the common stock as to dividend rights,
liquidation preference or both, may have full or limited voting rights and may
be convertible into shares of common stock. Accordingly, the issuance of shares
of preferred stock may discourage bids for our common stock or may otherwise
adversely affect the market price of our common stock.
For
purposes of the rights plan described below, our board of directors has
designated 1,000,000 shares of preferred stock to constitute Series I Junior
Participating Preferred Stock. For a description of the rights plan, please read
“—Stockholder Rights Plan.”
Authorized
but Unissued Stock
We have
125,000,000 authorized shares of common stock and 5,000,000 authorized shares of
preferred stock of which approximately 75,776,581 million shares of common stock
and no shares of preferred stock were outstanding as of the date of this
prospectus. One of the consequences of our authorized but unissued common stock
and preferred stock may be to enable our board of directors to make more
difficult or to discourage an attempt to obtain control of us. If, in the
exercise of its fiduciary obligations, our board of directors determined that a
takeover proposal was not in our best interest, the board could authorize the
issuance of those shares without stockholder approval. The shares could be
issued in one or more transactions that might prevent or make the completion of
the change of control transaction more difficult or costly by:
· diluting
the voting or other rights of the proposed acquiror or insurgent stockholder
group;
· creating
a substantial voting block in institutional or other hands that might undertake
to support the position of the incumbent board; or
· effecting
an acquisition that might complicate or preclude the takeover.
Stockholder
Action by Written Consent; Special Meetings of Stockholders
Our
certificate of incorporation does not prohibit action by written consent of
stockholders in lieu of a meeting. Special meetings of stockholders may be
called only by the board of directors, the chairman of the board, or the
president.
Amendment
of the By-laws
Under
Delaware law, the power to adopt, amend or repeal by-laws is conferred upon the
stockholders entitled to vote. A corporation may, however, in its certificate of
incorporation also confer upon the board of directors the power to adopt, amend
or repeal its by-laws. Our certificate of incorporation and by-laws grant our
board of directors the power to alter and repeal our by-laws at any regular or
special meeting of the board on the affirmative vote of a majority of the
directors then in office. Our stockholders may also alter or repeal our by-laws
by the affirmative vote of not less than 66% of the stockholders entitled to
vote.
Removal
of Directors
Directors
may be removed with cause by a vote of at least 66% of the voting power of our
outstanding voting stock. A vacancy on our board of directors may be filled by a
vote of a majority of the directors in office even if less than a quorum. A
director elected to fill a vacancy not resulting from an increase in the number
of directors serves for the remaining term of his predecessor or his earlier
death, resignation or removal.
Advance
Notice Procedure for Director Nominations and Stockholder Proposals
Our
certificate of incorporation and by-laws provide the manner in which
stockholders may give notice of business to be brought before an annual meeting.
In order for an item to be properly brought before the meeting by a stockholder,
the stockholder must be a holder of record at the time of the giving of notice
and must be entitled to vote at the annual meeting. The item to be brought
before the meeting must be a proper subject for stockholder action, and the
stockholder must have given timely advance written notice of the item. For
notice to be timely, it must be delivered to, or mailed and received at, our
principal executive office not less than 60 days nor more than 90 days prior to
the date of the meeting; provided, however, that in the event that less than 70
days’ notice or prior public disclosure of the date of the meeting is given or
made to stockholders, notice by the stockholder to be timely must be received
not later than the close of business on the 10th day following the day on which
such notice of the meeting was mailed or public disclosure was
made.
The
notice must set forth, as to each item to be brought before the annual meeting,
a description of the proposal and the reasons for conducting such business at
the annual meeting, the name and address, as they appear on our books, of the
stockholder proposing the item, the number of shares of each class or series of
capital stock beneficially owned by the stockholder, and any material interest
of the stockholder in the proposal. A notice with regards to stockholder
nominations for the election of directors must contain the name, age, business
address and residence of the director nominee, the principal occupation or
employment of the director nominee, the number of shares of each class or series
of capital stock beneficially owned by the director nominee, and any other
information relating to the director nominee that is required to be disclosed in
solicitations of proxies for the election of directors or is otherwise required
by Regulation 14A of the Securities Exchange Act of 1934, as
amended.
These
procedures may limit the ability of stockholders to bring business before a
stockholders meeting, including the nomination of directors and the
consideration of any transaction that could result in a change in control and
that may result in a premium to our stockholders.
Stockholder
Rights Plan
General
On
November 27, 2001, our board of directors issued a dividend of one preferred
share purchase right (a "Right") for each outstanding share of our common stock
held of record on that date and approved the further issuance of Rights with
respect to all shares of our common stock that are subsequently issued. The
Rights were issued subject to a Rights Agreement dated as of November 17, 2001
between us and American Stock Transfer & Trust Company, as Rights Agent.
Each Right now entitles the registered holder to purchase from us one
one-hundredth of a share of Series I Junior Participating Preferred Stock, par
value $0.00001 (“Series I Stock”), at a price of $5.00 in cash, subject to
adjustment. Until the occurrence of certain events described below, the Rights
are not exercisable, will be evidenced by the certificates for our common stock
and will not be transferable apart from our common stock. On November 21, 2005,
we amended the Rights Agreement to exempt the acquisition by Oil States Energy
Services of the shares of our common stock to which this prospectus relates from
the operation of the Rights Agreement as described below. The acquisition of 25%
or less of our outstanding common stock at the time of such acquisition by
certain direct transferees of Oil States Energy Services is also exempted from
the operation of the Rights Agreement pursuant to such amendment.
Detachment
of Rights; Exercise
The
Rights are currently attached to all certificates representing outstanding
shares of our common stock and no separate Right certificates have been
distributed. The Rights will separate from our common stock and a distribution
date ("Distribution Date") will occur upon the earlier of (1) 10 business days
following the public announcement that a person or group of affiliated or
associated persons (an "Acquiring Person") has acquired beneficial ownership of
15% or more of our outstanding common stock or (2) 10 business days following
the commencement or announcement of an intention to commence a tender offer or
exchange offer, the consummation of which would result in the beneficial
ownership by a person or group of 15% or more of our outstanding common
stock.
The
Rights are not exercisable until the Distribution Date. As soon as practicable
following the Distribution Date, separate certificates evidencing the Rights
will be mailed to holders of record of our common stock as of the close of
business on the Distribution Date and such separate certificates alone will
thereafter evidence the Rights.
If a
person or group were to acquire 15% or more of our common stock, each Right then
outstanding (other than Rights beneficially owned by the Acquiring Person which
would become null and void) would become a right to buy that number of shares of
our common stock (or, under certain circumstances, the equivalent number of one
one-hundredth of a share of Series I Stock) that at the time of such acquisition
would have a market value of two times the Purchase Price of the
Right.
If we
were acquired in a merger or other business combination transaction or more than
50% of our consolidated assets or earning power were sold, proper provision
would be made so that each holder of a Right would thereafter have the right to
receive, upon the exercise thereof at the then current Purchase Price of the
Right, that number of shares of common stock of the acquiring company which at
the time of such transaction would have a market value of two times the Purchase
Price of the Right.
Antidilution
and Other Adjustments
The
number of shares (or fractions thereof) of Series I Stock or other securities or
property issuable upon exercise of the Rights, and the Purchase Price payable,
are subject to customary adjustments from time to time to prevent dilution. The
number of outstanding Rights and the number of shares (or fractions thereof) of
Series I Stock issuable upon exercise of each Right are also subject to
adjustment in the event of a stock dividend on our common stock payable in our
common stock or any subdivision or combination of our common stock occurring, in
any such case, prior to the Distribution Date.
Exchange
Option
At any
time after the acquisition by a person or group of affiliated or associated
persons of beneficial ownership of 15% or more of our outstanding common stock
and before the acquisition by a person or group of 50% or more of our
outstanding common stock, our board of directors may, at its option, issue our
common stock in mandatory redemption of, and in exchange for, all or part of the
then outstanding and exercisable Rights (other than Rights owned by such person
or group which would become null and void) at an exchange ratio of one share of
our common stock (or one one-hundredth of a share of Series I Stock) for each
share of our common stock for which each Right is then exercisable, subject to
appropriate adjustment.
Redemption
of Rights
At any
time prior to the first public announcement that a person or group has become
the beneficial owner of 15% or more of our outstanding common stock, our board
of directors may redeem all but not less than all of the then outstanding rights
at a price of $0.001 per Right (the "Redemption Price"). The redemption of the
Rights may be made effective at such time, on such basis and with such
conditions as our board of directors in its sole discretion may establish.
Immediately upon the action of the board of directors ordering redemption of the
Rights, the right to exercise the Rights will terminate and the only right of
the holders of Rights will be to receive the Redemption Price.
Expiration;
Amendment of Rights
The
Rights will expire on December 31, 2011, unless earlier extended, redeemed or
exchanged. The terms of the Rights may be amended by our board of directors
without the consent of the holders of the Rights, including an amendment to
extend the expiration date of the Rights, and, provided a Distribution Date has
not occurred, to extend the period during which the Rights may be redeemed,
except that after the first public announcement that a person or group has
become or intends to become the beneficial owner of 15% or more of our
outstanding common stock, no such amendment may materially and adversely affect
the interests of holders of the Rights.
The
Rights have certain anti-takeover effects. The Rights will cause substantial
dilution to a person or group that attempts to acquire us without the approval
of our board of directors. The Rights should not, however, interfere with any
merger or other business combination that is approved by our board of
directors.
Limitation
of Liability of Officers and Directors
Our
directors will not be personally liable to us or our stockholders for monetary
damages for breach of fiduciary duty as a director, except, if required by
Delaware law, for liability:
· for
any breach of the duty of loyalty to us or our stockholders;
· for
an act or omission not in good faith that constitutes a breach of duty of the
director to us or involving intentional misconduct or a knowing violation of
law;
· for
any transaction from which the director derived an improper personal
benefit;
· under
Section 174 of the DGCL relating to unlawful stock repurchases or dividends;
and
· an
act or omission for which the liability of a director is expressly provided for
by an applicable statute.
As a
result, neither we nor our stockholders, through stockholders' derivative suits
on our behalf, have the right to recover monetary damages against a director for
breach of fiduciary duty as a director, including breaches resulting from
grossly negligent behavior, except in the situations described
above.
Indemnification
Agreements
We have
entered into indemnification agreements with our directors and officers that
may, in some cases, be broader than the specific indemnification provisions
contained in our certificate of incorporation, bylaws or the
DGCL. The indemnification agreements require us, among other things,
to indemnify our officers and directors against certain liabilities, other than
liabilities arising from willful misconduct, that may arise by reason of their
status or service as directors or officers. We believe that these
indemnification arrangements are necessary to attract and retain qualified
individuals to serve as directors and officers.
Insofar
as indemnification for liabilities arising under the Securities Act may be
permitted to directors, officers or persons controlling us pursuant to the
foregoing provisions, we have been informed that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy
as expressed in the Act and is, therefore, unenforceable.
Delaware
Anti-Takeover Law and Certain Charter and Bylaw Provisions
Our
certificate of incorporation, bylaws and the DGCL contain certain provisions
that could discourage potential takeover attempts and make it more difficult for
stockholders to change management or receive a premium for their
shares.
Delaware law. We
are subject to Section 203 of the DGCL, an anti-takeover law. In general, the
statute prohibits a publicly-held Delaware corporation from engaging in a
business combination with an “interested stockholder” for a period of three
years after the date of the transaction in which the person became an interested
stockholder. A “business combination” includes a merger, sale of 10% or more of
our assets and certain other transactions resulting in a financial benefit to
the stockholder. For purposes of Section 203, an “interested stockholder” is
defined to include any person that is:
· the
owner of 15% or more of the outstanding voting stock of the
corporation;
· an
affiliate or associate of the corporation and was the owner of 15% or more of
the voting stock outstanding of the corporation, at any time within three years
immediately prior to the relevant date; and
· an
affiliate or associate of the persons described in the foregoing bullet
points.
However,
the above provisions of Section 203 do not apply if:
· the
board of directors approves the transaction that made the stockholder an
interested stockholder prior to the date of that transaction;
· after
completion of the transaction that resulted in the stockholder becoming an
interested stockholder, that stockholder owned at least 85% of our voting stock
outstanding at the time the transaction commenced, excluding shares owned by our
officers and directors; or
· on
or subsequent to the date of the transaction, the business combination is
approved by our board of directors and authorized at a meeting of our
stockholders by an affirmative vote of at least two-thirds of the outstanding
voting stock not owned by the interested stockholder.
Stockholders
may, by adopting an amendment to the corporation's certificate of incorporation
or bylaws, elect for the corporation not to be governed by Section 203,
effective 12 months after adoption. Neither our certificate of incorporation nor
our bylaws exempt us from the restrictions imposed under Section 203. It is
anticipated that the provisions of Section 203 may encourage companies
interested in acquiring us to negotiate in advance with our board.
Charter and bylaw provisions.
Delaware law permits any Delaware corporation to classify its board of directors
into as many as three (3) classes as equally as possible with staggered terms of
office. After initial implementation of a classified board, one class will be
elected at each annual meeting of the stockholders to serve for a term of one,
two or three years (depending upon the number of classes into which directors
are classified) or until their successors are elected and take office. Our
certificate of incorporation and bylaws provide for a classified board of
directors by dividing the board into three (3) classes, with no class having
more than one director more than any other class. The stockholders of a Delaware
corporation with a classified board of directors may remove a director only “for
cause” unless the company's certificate of incorporation provides otherwise. Our
bylaws restrict the removal of a director except “for cause.”
Transfer
Agent and Registrar
Our
Transfer Agent and Registrar for our common stock is American Stock Transfer
& Trust Company. Its phone number (800) 937-5449.
SELLING
STOCKHOLDERS
The
shares of our common stock covered by this prospectus are being offered by the
selling stockholder referenced in the table below.
This
prospectus does not and will not cover subsequent sales of common stock
purchased from the selling stockholder named in this prospectus.
The
following table sets forth the name of the selling stockholder, the amount of
shares of our common stock beneficially owned by the selling stockholder prior
to the offering, the amount being offered for the stockholder's account and the
amount to be owned by such stockholder after completion of the offering,
assuming that all shares held are sold pursuant to this prospectus. Because the
selling stockholder may transfer all, some or none of the shares pursuant to
this prospectus, or may transfer or otherwise dispose of shares in transactions
exempt from the registration requirements of the Securities Act of 1933, we do
not know the exact number of shares of our common stock or the percentage of
common stock outstanding that will be held by the selling stockholder after
completion of the sale of shares hereunder. The selling stockholder is under no
obligation to sell or dispose of all or any portion of the shares held by it,
nor is the selling stockholder obligated to sell or dispose of any such shares
immediately pursuant to this prospectus. The selling stockholder does not
beneficially own any other common stock issued by us.
We
prepared the table based on information supplied to us by the selling
stockholder. We have not sought to independently verify such
information.
Name
|
|
Number of Shares of Common Stock Beneficially
Owned Prior to the Offering (1)
|
|
Number of Shares of Common Stock Being Offered
Hereby
|
|
Number of Shares of Common Stock Beneficially
Owned After Completion of the Offering (1)
|
|
Percentage of Shares of Common Stock Beneficially
Owned After Completion of the Offering
|
|
|
|
|
|
|
|
|
|
Oil
States Energy Services, Inc.(2)(3)
|
|
11,512,137
|
|
11,512,137
|
|
—
|
|
*
|
(1)
|
Ownership
is determined in accordance with Rule 13d-3 under the Securities Exchange
Act of 1934.
|
(2)
|
Douglas
E. Swanson, Chairman of our Board of Directors, is a director of, and
former Chief Executive Officer of, Oil States International, Inc., the
parent of Oil States Energy Services,
Inc.
|
(3)
|
Cindy
B. Taylor, Chief Executive Officer and member of the Board of Directors of
Oil States International, Inc., the parent of Oil States Energy Services,
Inc., served on our Board of Directors from March 3, 2006 to December 3,
2007.
|
PLAN
OF DISTRIBUTION
We are
registering the shares of common stock on behalf of the selling stockholder
pursuant to the terms of a registration rights agreement.
The
selling stockholder, including some of its transferees who may later hold its
interest in the shares of our common stock covered by this prospectus and who
are otherwise entitled to resell their shares using this prospectus, may sell
the shares of common stock covered by this prospectus from time to time in any
legal manner selected by the selling stockholder, including directly to
purchasers or through underwriters, brokers, dealers, agents or other persons,
who may receive compensation in the form of discounts, concessions or
commissions from the selling stockholder or the purchasers. These discounts,
concessions or commissions as to any particular underwriter, broker, dealer,
agent or other person may be in excess of those customary in the types of
transactions involved. The selling stockholder will act independently of us in
making decisions with respect to the pricing, timing, manner and size of each
sale of the common stock covered by this prospectus.
The
selling stockholder has advised us that the shares may be sold in one or more
transactions at fixed prices, at prevailing market prices at the time of sale,
at prices related to the prevailing market prices, at varying prices determined
at the time of sale and/or at negotiated prices. These sales may be effected at
various times in one or more transactions, which may include:
· ordinary
brokers' transactions;
· transactions
involving cross or block trades or otherwise on the American Stock
Exchange;
· transactions
in the over-the-counter market;
· transactions
otherwise than on the American Stock Exchange or in the over-the-counter
market;
· transactions
in which brokers, dealers or underwriters purchase the shares for resale,
including without limitation on a firm commitment or best efforts basis or for
their own account;
· transactions
"at the market" to or through market makers of our common stock or into an
existing market for our common stock, and in other ways not involving market
makers or established trading markets, including direct sales of the shares to
purchasers or sales through agents;
· privately
negotiated transactions;
· any
other method permitted under applicable law; or
· any
combination of the foregoing.
In
addition, the selling stockholder may also enter into hedging and/or other
monetization transactions. For example, the selling stockholder
may:
· enter
into transactions with a broker-dealer or affiliate of a broker-dealer or other
third party in connection with which that other party will become a selling
stockholder and engage in short sales of our common stock under this prospectus,
in which case the other party may use shares of our common stock received from
the selling stockholder to close out any short positions;
· itself
sell short our common stock under this prospectus and use shares of our common
stock held by it to close out any short positions;
· enter
into options, forwards or other transactions that require the selling
stockholder to deliver, in a transaction exempt from registration under the
Securities Act, our common stock to a broker-dealer or an affiliate of a
broker-dealer or other third party who may then become a selling stockholder and
publicly resell or otherwise transfer our common stock under this prospectus, as
amended or supplemented to reflect such transaction; or
· loan
or pledge our common stock to a broker-dealer or affiliate of a broker-dealer or
other third party who may then become a selling stockholder and sell the loaned
shares or, in an event of default in the case of a pledge, become a selling
stockholder and sell the pledged shares, in each case under this prospectus, as
amended or supplemented to reflect such transaction.
The
selling stockholder may also may donate the shares registered hereunder to a
third party and such donee may effect sales of the shares pursuant to this
prospectus, as supplemented or amended to reflect such transaction.
To our
knowledge, there are currently no plans, arrangements or understandings between
the selling stockholder and any underwriter, broker, dealer, agent or other
person regarding the sale of common stock by the selling stockholder. To the
extent required, the shares to be sold, the name of the selling stockholder, the
respective purchase prices and public offering prices, the names of any
underwriter, broker, dealer, agent or other person, and any applicable
commissions or discounts with respect to a particular offer will be set forth in
an accompanying prospectus supplement filed with the SEC under Rule 424(b) under
the Securities Act or, if appropriate, a post-effective amendment to the shelf
registration statement of which this prospectus is a part. The selling
stockholder may sell any or all of the shares of our common stock offered by it
pursuant to this prospectus. In addition, there can be no assurance that the
selling stockholder will not transfer, devise or gift the shares of common stock
by other means not described in this prospectus.
There can
be no assurance that the selling stockholder will sell any or all of the shares
of common stock pursuant to this prospectus. In addition, any common stock
covered by this prospectus that qualifies for sale pursuant to an exemption from
the registration requirements of the Securities Act (including without
limitation Rule 144 thereunder) may be sold pursuant to that exemption (subject
to the terms of the stockholder agreement) rather than under this prospectus.
The common stock may be sold in some states only through registered or licensed
brokers or dealers. In addition, in some states the shares of our common stock
may not be sold unless they have been registered or qualified for sale or an
exemption from registration or qualification is available and complied
with.
The
aggregate proceeds to the selling stockholder from the sale of the shares
offered by it will be the purchase price of the shares less discounts and
commissions, if any. If the shares of common stock are sold through underwriters
or broker-dealers, the selling stockholder will be responsible for underwriting
discounts and commissions and/or agent's commissions. We will not receive any of
the proceeds from the sale of the shares of common stock covered by this
prospectus.
The
selling stockholder has acknowledged that it understands its obligations to
comply with the provisions of the Exchange Act and the rules and regulations
thereunder relating to stock manipulation, including without limitation
Regulation M, which may limit the timing of purchases and sales of our common
stock by the selling stockholder. In addition, Regulation M may restrict the
ability of any person engaged in the distribution of the common stock to engage
in market making activities with respect to the particular common stock being
distributed. This may affect the marketability of the common stock and the
ability of any person or entity to engage in market-making activities with
respect to the common stock.
The
selling stockholder and any underwriters, brokers, dealers, agents or other
persons who act in connection with the sale of common stock hereunder may be
deemed to be "underwriters" as that term is defined in the Securities Act, and
any discounts, commissions or fees received by them and any profit on the resale
of the common stock as principal might be deemed to be underwriting discounts
and commissions under the Securities Act. If the selling stockholder is deemed
to be an "underwriter" within the meaning of the Securities Act, it will be
subject to the prospectus delivery requirements of the Securities
Act.
Subject
to certain limitations, we have agreed to indemnify the selling stockholder its
officers, directors, employees, partners, attorneys and agents, each
underwriter, broker or other person acting on behalf of the selling stockholder
and each person who controls any of the foregoing persons against certain
liabilities, including specified liabilities under the Securities Act, or to
contribute with respect to payments which such persons may be required to make
in respect of such liabilities. Subject to certain limitations, the selling
stockholder has agreed to indemnify us, our directors, our officers who sign the
registration statement of which this prospectus is a part and each person who
controls any of the foregoing persons against certain liabilities, including
specified liabilities under the Securities Act, but only to the extent such
liabilities are caused by written information furnished to us by it for
inclusion in this prospectus or any supplement or amendment hereto to contribute
with respect to payments in connection with such liabilities.
We have
agreed to pay all of the costs, fees and expenses incident to the registration
of the resale of the selling stockholder's common stock. We will not pay any
legal fees or other expenses of the selling stockholder or any commissions, fees
and discounts of underwriters, brokers, dealers and agents.
We will
use our reasonable best efforts to keep the registration statement of which this
prospectus is a part effective until the earlier of (i) the later of (A) March
3, 2008 and (B) such time as the selling stockholder ceases to own at least 5%
of our outstanding shares of common stock and (ii) the later of (x) March 3,
2010 and (y) the earliest date that the selling stockholder may then dispose of
all its registrable shares without restriction under Rule 144(k) promulgated
under the Securities Act. Notwithstanding the foregoing, our obligation to keep
such registration statement effective shall immediately terminate upon the sale
of all registrable shares covered by any shelf registration statement that we
file in the manner set forth and as contemplated in such shelf registration
statement.
LEGAL
MATTERS
The
validity of the issuance of the common stock covered by this prospectus has been
passed upon for us by Thompson & Knight LLP.
EXPERTS
Our
consolidated financial statements as of December 31, 2007 and 2006, and for each
of the three years in the period ended December 31, 2007, and the effectiveness
of the Company's internal control over financial reporting as of December 31,
2007 appearing in our Annual Report (Form 10-K) for the year ended December 31,
2007, have been so incorporated in reliance upon the reports of UHY LLP,
independent registered public accounting firm, given on the authority of such
firm as experts in accounting and auditing.
WHERE
YOU CAN FIND MORE INFORMATION
We have
filed with the SEC a post−effective amendment to the registration on Form S−3 on
a registration statement on Form S−1 under the Securities Act of 1933, as
amended, with respect to the shares of common stock being offered by this
prospectus. Certain information in the registration statement has been omitted
from this prospectus in accordance with the rules and regulations of the SEC.
For further information with respect to the company and the common stock offered
by this prospectus, we refer you to the registration statement and its exhibits.
Statements contained in this prospectus as to the contents of any contract or
any other document referred to are not necessarily complete, and in each
instance, we refer you to the copy of the contract or other document filed as an
exhibit to the registration statement. Each of these statements is qualified in
all respects by this reference.
We
electronically file annual, quarterly and special reports, proxy and information
statements and other information with the SEC. You may read and copy any
materials we file with the SEC at the SEC’s Public Reference Room at 100 F
Street, N.E., Washington, D.C. 20549. You may obtain information on the
operation of the Public Reference Room by calling the SEC at 1−800−SEC−0330. The
SEC also maintains an Internet site that contains reports, proxy and information
statements, and other information regarding issuers that file electronically
with the SEC. The address of that website is www.sec.gov.
FORWARD−LOOKING
STATEMENTS
Included
and incorporated by reference in this prospectus are certain forward-looking
statements, within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. All statements, other than statements of historical facts,
included or incorporated by reference in this prospectus that address
activities, events or developments that we expect or anticipate will or may
occur in the future are forward-looking statements, including statements
regarding our future financial position, growth strategy, budgets, projected
costs, and plans and objectives of management for future
operations. We use the words "may," "will," "expect," "anticipate,"
"estimate," "believe," "continue," "intend," "plan," "budget" and other similar
words to identify forward-looking statements. You should read statements that
contain these words carefully and should not place undue reliance on these
statements. Although we believe our expectations reflected in these
forward-looking statements are based on reasonable assumptions, no assurance can
be given that these expectations or assumptions will prove to have been correct.
Important factors that could cause actual results to differ materially from the
expectations reflected in the forward-looking statements include, but are not
limited to, the following factors and the other factors described under the
caption "Risk Factors" in this prospectus and in our Form 10-K incorporated by
reference in this prospectus:
•
competition;
• changes
in economic or political conditions in the markets in which we operate;
and
• the
inherent risks associated with our operations, such as equipment defects,
malfunctions and natural disasters.
We
believe that it is important to communicate our expectations of future
performance to our investors. However, events may occur in the future that we
are unable to accurately predict or control. We do not undertake any obligation
to publicly update or revise publicly any forward-looking
statements.
12